Related Experiment Video
Updated: Oct 21, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Scratching Below the Ovarian Cancer GWAS Surface
Lauren C Peres1, Alvaro N Monteiro2
1Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Researchers identified a new genetic factor, ULK1, linked to better progression-free survival in ovarian cancer patients. This discovery could improve understanding and treatment outcomes for this deadly disease.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Ovarian cancer survival rates remain poor despite treatment advancements.
- Identifying novel prognostic factors is crucial for reducing mortality.
- Genetic factors influencing ovarian cancer outcomes are underexplored.
Purpose of the Study:
- To investigate genetic factors associated with progression-free survival in ovarian cancer.
- To identify novel prognostic markers for ovarian cancer patients.
Main Methods:
- Genome-wide association study using data from the Ovarian Cancer Association Consortium.
- Analysis of patients receiving debulking surgery and standard first-line chemotherapy.
- Experimental validation implicating the ULK1 gene.
Main Results:
- A significant genetic locus at 12q24.33 was associated with progression-free survival.
- The ULK1 gene, involved in autophagy, is suggested as the target of this association.
- This finding provides a novel genetic insight into ovarian cancer prognosis.
Conclusions:
- The ULK1 gene represents a potential prognostic factor in ovarian cancer.
- Further research is needed to translate these findings into clinical practice.
- This study opens new avenues for understanding ovarian cancer progression.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024